LPAA

Launch One Acquisition Corp. Class A Ordinary shares

$10.78 -0.14%

Recent alerts on LPAA

All signals →

News Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

News Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome

Get push alerts for LPAA

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS